← Back to SPTX

Seaport Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 03/08/2026Mar 2026Filed 03/08/2026Jun 2025Filed 03/08/2026Mar 2025Filed 03/08/2026
−$63−$25−$15−$13
−$1.78−$10.34−$6.40−$5.65
35—2.42.3

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.